Issue #244
- San Francisco: 3TC Available Now to Residents through ADAP Program
- Protease Inhibitors: Patient Education Critical
- Indinavir (Crixivan«) Access and Distribution
- AIDS Research at NIH: Study Panel Issues Major Report
- Viral Load: Inconclusive FDA Hearing
- AZT, ddI, and ddC Combinations at FDA Advisory Hearing
- Cidofovir Recommended for Approval for CMV Retinitis
- California: Clinical Trials Computer Service Now Available Statewide
- San Francisco Protest Against Meeting Disruptions
- California: AB 2812 Would Outlaw Anonymous Testing
- AIDS Medications Needed Abroad
source: AIDS Treatment News
